Corporate Governance | Regeneron Pharmaceuticals Inc.

Date	Name	Title	Filing	Type	Shares Traded	Price	Total Held
Sep 17, 2003	YANCOPOULOS GEORGE Director, EVP, CSO, & Pres Regn Res Labs Trans History: 673	Director, EVP, CSO, & Pres Regn Res Labs	Form 4	Open market or private sale of non-derivative or derivative security	2,400	$20.26	111,251
Sep 19, 2013	VAGELOS P ROY Director, Chairman of the Board Trans History: 742	Director, Chairman of the Board	Form 4	Open market or private sale of non-derivative or derivative security	6,780	$303.49	111,255
Jan 04, 2004	SCHLEIFER LEONARD S Director, Chief Exec Officer & President Trans History: 427	Director, Chief Exec Officer & President	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	14,656	$15.01	111,290
Feb 14, 2012	STAHL NEIL SVP Research and Development S Trans History: 660	SVP Research and Development S	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	21,352	$111.01	111,405
Aug 20, 2020	SING GEORGE L Director Trans History: 326	Director	Form 4	Open market or private sale of non-derivative or derivative security	3,783	$615.51	111,632
Sep 17, 2003	SCHLEIFER LEONARD S Director, Chief Exec Officer & President Trans History: 427	Director, Chief Exec Officer & President	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	88,007	$20.95	112,088
Feb 06, 2012	GOLDBERG MURRAY A SVP Finance and Admin CFO Trea Trans History: 645	SVP Finance and Admin CFO Trea	Form 4	Exercise or conversion of derivative security exempted pursuant to Rule 16b-3	12,788	$24.86	112,247
Dec 14, 2012	STAHL NEIL SVP Res and Devel Sciences Trans History: 660	SVP Res and Devel Sciences	Form 4	Grant, award or other acquisition pursuant to Rule 16b-3(d)	112,500	--	112,500
Nov 18, 2015	SING GEORGE L Director Trans History: 326	Director	Form 4	Open market or private sale of non-derivative or derivative security	3,000	$580.00	112,772
May 27, 2015	SING GEORGE L Director Trans History: 326	Director	Form 4	Open market or private sale of non-derivative or derivative security	5,000	$515.00	112,772

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

Investors & Media